Biovail CEO challenged to TV debate; Mylan nabs Effexor approval

> The proxy fight between Biovail founder Eugene Melnyk and the company's management took a weird turn as the man Melnyk wants to head the company challenged its current CEO to a televised debate. Report

> Mylan Pharmaceuticals got the FDA's final nod for its copycat version of Effexor and plans to ship immediately; the company also got a tentative nod for its version of Sanofi Aventis' blood pressure med Avalide. Report

> Allergan received FDA approval for Trivaris, an injectable eye drug to treat retinal diseases. Report

> The Florida Medical Examiners Commission found that the rate of deaths caused by prescription drugs was three times the rate of deaths caused by all illicit drugs combined. Report

> Schering-Plough spent $520,000 in the first quarter to lobby on patent reform legislation, drug safety and other issues, according to a disclosure report. Report

> Medtronic got FDA approval to market its Starfix lead, a wire that delivers electrical pulses to the heart from a device that regulates heartbeat. Report

And Finally... How can doctors ensure patients take their medicine? Simple, give them a reward. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.